BACIX | VENAX | BACIX / VENAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 20 years | - |
Gain YTD | 3.976 | 4.793 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 100000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 300M | 9.38B | 3% |
Annual Yield % from dividends | 3.06 | 2.93 | 104% |
Returns for 1 year | 6.50 | 6.09 | 107% |
Returns for 3 years | 37.28 | 39.04 | 95% |
Returns for 5 years | 79.42 | 77.70 | 102% |
Returns for 10 years | 32.51 | 13.66 | 238% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SSIQX | 11.55 | -0.09 | -0.77% |
State Street International Stock Sel K | |||
BSVAX | 10.58 | -0.11 | -1.03% |
BlackRock Sustainable US Value Eq Inv A | |||
SGQAX | 42.12 | -0.58 | -1.36% |
DWS International Growth A | |||
GSPSX | 30.34 | -0.58 | -1.88% |
Goldman Sachs Large Cap Core Svc | |||
ASVDX | 10.53 | -0.25 | -2.32% |
American Century Small Cap Value R6 |